Greenlight Biosciences Holdings Stock Debt To Equity
GreenLight Biosciences Holdings fundamentals help investors to digest information that contributes to GreenLight Biosciences' financial success or failures. It also enables traders to predict the movement of GreenLight Stock. The fundamental analysis module provides a way to measure GreenLight Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GreenLight Biosciences stock.
GreenLight |
GreenLight Biosciences Holdings Company Debt To Equity Analysis
GreenLight Biosciences' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current GreenLight Biosciences Debt To Equity | 9.81 % |
Most of GreenLight Biosciences' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GreenLight Biosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, GreenLight Biosciences Holdings has a Debt To Equity of 9.814%. This is 81.67% lower than that of the Biotechnology sector and 49.31% lower than that of the Health Care industry. The debt to equity for all United States stocks is 79.85% higher than that of the company.
GreenLight Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GreenLight Biosciences' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of GreenLight Biosciences could also be used in its relative valuation, which is a method of valuing GreenLight Biosciences by comparing valuation metrics of similar companies.GreenLight Biosciences is currently under evaluation in debt to equity category among its peers.
GreenLight Fundamentals
| Number Of Shares Shorted | 4.79 K | |||
| Revenue | 6.38 M | |||
| EBITDA | (153.99 M) | |||
| Net Income | (167.06 M) | |||
| Cash And Equivalents | 34.75 M | |||
| Cash Per Share | 10.01 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 9.81 % | |||
| Book Value Per Share | (61.86) X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Number Of Employees | 280 | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
| Working Capital | 35.75 M | |||
| Z Score | -7.05 | |||
| Net Asset | 148.6 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in GreenLight Stock
If you are still planning to invest in GreenLight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GreenLight Biosciences' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |